Symbols

SANA

Sana Biotechnology·NASDAQ

--(--)

SANA Profile

Sana Biotechnology, Inc.

A company focused on creating and delivering engineered cells as medicines

Industry

Biological Technology

Established Date

07/13/2018

Listing Date

02/04/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

142

Fiscal Year Ends

12-31

Website

www.sana.com

Security Type

Common stock

Office address

188 East Blaine Street, Suite 350, Seattle, Washington 98102

Business

Introduction

Sana Biotechnology, Inc., was incorporated in Delaware on July 13, 2018. The company is a biotechnology company that develops drugs using engineered cells. Its business includes identifying and developing potential product candidates, conducting preclinical research, and building production capabilities. Sana Biotechnology is also committed to the preparation and execution of clinical trials of its product candidates and provides support for clinical trials of product candidates developed using its technology. In addition, the company focuses on new technology acquisition, staffing, business planning, maintaining its intellectual property portfolio, raising capital and providing general administrative support for the above-mentioned tasks.